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Abstract
Cardiovascular disease is one of the leading causes of death worldwide, in particular myo-
cardial dysfunction, which may lead to heart failure eventually. Understanding the electro-
mechanics of the heart will help in developing more effective clinical treatments. In this
paper, we present a multi-scale electro-mechanics model of the left ventricle (LV). The Hol-
zapfel-Ogden constitutive law was used to describe the passive myocardial response in tis-
sue level, a modified Grandi-Pasqualini-Bers model was adopted to model calcium
dynamics in individual myocytes, and the active tension was described using the Niederer-
Hunter-Smith myofilament model. We first studied the electro-mechanics coupling in a sin-
gle myocyte in the healthy and diseased left ventricle, and then the single cell model was
embedded in a dynamic LV model to investigate the compensation mechanism of LV pump
function due to myocardial dysfunction caused by abnormality in cellular calcium dynamics.
The multi-scale LV model was solved using an in-house developed hybrid immersed bound-
ary method with finite element extension. The predictions of the healthy LV model agreed
well with the clinical measurements and other studies, and likewise, the results in the failing
states were also consistent with clinical observations. In particular, we found that a low level
of intracellular Ca2+ transient in myocytes can result in LV pump function failure even with
increased myocardial contractility, decreased systolic blood pressure, and increased dia-
stolic filling pressure, even though they will increase LV stroke volume. Our work suggested
that treatments targeted at increased contractility and lowering the systolic blood pressure
alone are not sufficient in preventing LV pump dysfunction, restoring a balanced physiologi-
cal Ca2+ handling mechanism is necessary.
Introduction
Myocardial dysfunction is a considerable social and economic burden because it can lead to
heart failure due to repeated stresses and injuries [1]. However, our understanding of cardiac
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dysfunction remains incomplete. Mann and Bristow [2] suggested that heart failure could be
viewed as a biomechanical model orchestrated by different subsystems, and the downstream
biological remodelling is one of the drivers leading to myocardial dysfunction progression.
Multi-scale and multi-physics biomechanical modelling of heart dynamics provides a unique
way to gain insights of myocardial function and holds the potential for patient risk stratifica-
tion and clinical decision making [3, 4].
Developing physiologically realistic heart models is complicated by many challenges [5],
such as the complex anatomical geometry, nonlinear material responses of the myocardium,
fluid-structure interaction, and issues across different length/function scales. In the last several
decades, many nonlinear models of cardiac mechanics have been developed using the finite
element (FE) method [6–9]. Different constitutive laws are introduced to characterize myocar-
dium, such as the “pole-zero” constitutive law [9] and “Holzapfel-Ogden” law [10]. A recent
review on heart modelling is provided in Ref [5]
In addition to the aforementioned structure-only ventricular models, immersed boundary
(IB) method has also been used in modelling ventricular dynamics since the 1970s [11].
Recently, Griffith and Luo [12] have developed a hybrid IB with finite element method (IB/FE)
that describes the immersed structure using the finite elements elasticity. Gao et al. [13] suc-
cessfully applied the IB/FE framework to an imaging-derived subject-specific human LV
model in diastole, as well as a diseased heart with myocardial infarction [14]. Later, Cai et al.
[15] developed a more automatic procedure to construct mathematical models from medical
images, and simulated the end-diastolic (ED) and end-systolic (ES) behaviours of a healthy left
ventricle. Their results demonstrated that it is possible to simulate realistic ventricular dynam-
ics using the IB/FE approach in conjunction with structure-based constitutive models [13].
However, the electrophysiological modelling of the heart was oversimplified in their models.
Myocardial contraction is highly dependent on the dynamics of calcium ion (Ca2+) in indi-
vidual myocytes [16]. Numerious myocyte models exist in the literature [17], such as the model
developed by Luo et al. [18], the FK model by Fenton et al. [19], and so on. Human ventricular
myocyte models are emerging in recent years. For example, the ten Tusscher model [20], the
OVVR model [21], and the Grandi-Pasqualini-Bers (GPB) model [22]. The electrophysiology
models in single myocyte have proven to be very useful to study the mechanisms underlying
disturbances of Ca2+ due to functional dysfunction [23] and the effects of drugs [24].
The failing heart undergoes continuous electrical-physiological, metabolic and structural
remodelling in order to compensate the loss of functioning myocytes [2]. Ca2+ is the most
important ion regulating myocardial excitation-contraction coupling [16]. Continuous
remodelling of ion channels in failing myocyte, such as a significant increase in the late Na+
current [25], will cause AP duration prolongation and altered intracellular Ca2+ homeostasis,
the hallmark characteristics of failing myocytes [26]. Several studies [27–29] have used the
GPB model to explore excitation–contraction coupling and repolarization abnormalities in
single human myocyte, in particular the Ca2+ handling process.
The multiscale nature of the heart requires one to model myocyte dynamics at cellular level
and the electrophysiology at tissue level [17]. Many cardiac mechanical models, our previous
models included, have not incorporated the detailed electrophysiology model for the myo-
cytes. These models assumed a homogeneous and simultaneous contraction in the LV wall,
and used prescribed intracellular calcium transient (CaT), or specified contraction not explic-
itly based on electrophysiology [7, 14, 30]. In this work, we coupled a more detailed model of
myocyte ion dynamics for excitation-contraction coupling into the tissue-level mechanics to
study how Ca2+ dynamics at the cellular level affects the myocardial function at organ level, in
particular in failing heart. This was achieved by extending our IB/FE LV model [13, 14] by
embedding a modified GPB model together with a myofilament model. The new coupled
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model was then used to study the myocardial active contraction at both cellular- and tissue-
levels in healthy and failing states.
The remaining of the paper is organised as follows. In Methodology, we report how we use
a modified GPB model to model the myocyte electrophysiology [29], and the filament model
by Niederer et al. [31] (henceforth referred to as the NHS model) for the active contraction.
This is followed by studying four different cases of myocyte contraction from healthy to failing
states. In Results, we describe how we embed the active tension generation using the NHS and
GPB model into a IB/FE LV model, to study the pump function in the healthy case and the
worst failing case. We subsequently show how changes in cellular electrophysiology may affect
the LV pump function at the organ level. The paper ends with Discussion and Conclusions.
Methodology
Myocyte dynamics at cellular level
Ion dynamics: The GPB model. In this study, a modified GPB model by Cardona et al.
[29] was used to simulate the Ca2+ dynamics in healthy and failing states. The reasons for
choosing the GPB model were that (1) it matches experimental data well [22]; (2) it is adequate
to analyse action potential with detailed Ca2+ dynamics, which plays a crucial role in excita-
tion-contraction in myocardium [16]; (3) other studies have demonstrated that it can repro-
duce the electrical changes of failing myocytes caused by remodelling in ion channels and
transporters [28, 29]. The original GPB model consists of 38 ordinary differential equations,
which describe the kinetics of different ion channels. Details of the GPB model and parameters
are given in S1 and S2 Appendices.
In the failing myocytes, the intracellular sodium concentration and Ca2+ handing are closely
related. For example, the intracellular sodium concentration, especially INaL, is increased in
failing myocytes, which contributes to cellular Ca2+ accumulation. The introduced INaL in the
modified GBP model was modelled following the Hodgkin-Huxley formula [32],
INaLjunc ¼ Fjunc gNaL m
3
L hLðVm   EjuncÞ; ð1Þ
INaLsl ¼ Fsl gNaL m
3
L hLðVm   EslÞ; ð2Þ
INaL ¼ INaLjunc þ INaLsl ; ð3Þ
and
dmL
dt
¼ am;L ð1   mLÞ   bm;L mL;
d hL
dt
¼
hL;1   hL
thl
;
am;L ¼
0:32ðVm þ 47:13Þ
1   e  0:1ðVmþ47:13Þ
;
bm;L ¼ 0:08e
 
Vm
11 ;
hL;1 ¼
1
1   e
Vm þ 91
6:1
;
where gNal is the maximum conductance, mL is the activation gate, hL is the steady-state inacti-
vation gate, τhl (233 ms) is the time constant of inactivation, Ejunc and Esl are, respectively, the
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Nernst potential for the sodium ion in the junctional and subsarcolemmal compartments (see
S1 and S2 Appendices for details). Cardona et al. [29] found that the most impactful parame-
ters on Ca2+ handing are the sarcoplasmic reticulum Ca-ATPase (SERCA) function, INaL, the
Na/K pump current (INak), the sarcoplasmic reticulum leak current (Ileak), the background Ca
current (ICab) and the Na-Ca exchanger current (Incx). The modified GPB model was further
extended by Trenor et al. [28], who introduced the impact factors to simulate the transition
from healthy to failing states. The impact factors are coefficients that can change the parame-
ters on Ca2+ handling in the modified GPB model. The final formulations of the modified GPB
model employed in this study are given in S3 Appendix.
Based on the work of Trenor et al. [28], four cases were designed to represent different
failing states; Case A: the healthy state, Cases B and C: two intermediate failing states, and
Case D: the end-stage failure state. The impact factors of Case A and Case D were adopted
from [28], and the impact factors of Case B and Case C were obtained by reducing the values
of Case A by one-third and two-thirds of the difference between Cases A and D, as shown in
Table 1. In healthy state, the peak value of the intracellular CaT obtained by this modified
GPB model were between 0.3 μM and 0.4 μM. Thus, in order to make the peak CaT to be
around 1 μM which was needed by the later active contraction model [31], two diffusion
constants were changed (needing to note that changes of JCajuncsl and JCaslmyo may not be the
ideal way to obtain an intracellular CaT profile with a peak value of 1 μM), they were (1) the
diffusion constant between the junctional cleft and subscarcolemmal: JCajuncsl ¼ 1:2362 
10  12 L/ms, and (2) the diffusion constant between the subsarcolemmal and the bulk cytosol
space: JCaslmyo ¼ 7:4485  10
  12 L/ms.
Myofilament active contraction: The NHS model. The active tension in each myocyte, T
(t), was modelled as a function of the myocyte stretch (λf), the stretch rate (
dlf
dt ), and the intra-
cellular CaT [31]. Details of the NHS model and the parameters are given in S4 Appendix. To
study the influence of CaT on the active tension generation in individual myocytes, the intra-
cellular CaT from the modified GPB model was coupled to the NHS model to trigger active
Table 1. Impact factors in the four different cases based on the modified GPB model.
fhl fNaL fKi fNaK fNabk fCabk fncx fto fSRleak fSRca fEC50SR
Case A 1 1 1 1 1 1 1 1 1 1 1
Case B 1.333 1.333 0.893 0.833 0.667 1.177 1.25 0.8 2.333 0.833 0.963
Case C 1.666 1.666 0.787 0.667 0.333 1.353 1.5 0.6 3.667 0.667 0.927
Case D 2 2 0.68 0.5 0 1.530 1.75 0.4 5 0.5 0.89
impact factor the relative physical quantity of the impact factor
fhl the time constant of inactivation(τhl)
fNaL the late sodion current (INaL)
fki the inward rectifier K current (IKi)
fNaK the Na/K pump current (INaK)
fNabk the background Na current (INabk)
fCabk the background Ca current (ICabk)
fncx the Na-Ca exchanger current (Incx)
fSRleak the current density of the sarcoplasmic reticulum leak current (JSRleak)
fto the transient outward K current (Ito)
fSRrca the current density of the sarcoplasmic reticulum Ca-ATPase (Jserca)
fEC50SR the half maximal effective concentration in sarcoplasmic reticulum (EC50SR)
https://doi.org/10.1371/journal.pone.0174834.t001
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contraction. We further assumed that in the initial time T = 0 kPa, and λf = 1,
dlf
dt ¼ 0 during
myocyte contraction. Therefore, the simulated active tension in one myocyte corresponded to
an isometric tension experiment at resting length.
Myocardial dynamics at organ level: The LV model
IB/FE formulation. The in-house developed IB/FE framework was employed to simulate
the LV contraction [12], in which the Lagrangian equations of the LV dynamics were approxi-
mated on an FE mesh, and the Eulerian equations of the fluid were approximated on a Carte-
sian grid [11]. A regularised delta function δ was used to describe the fluid-structure
interaction, which implies that the IB/FE approach permits nonconforming discretization of
the fluid and structure domains. In brief, the governing equations of the coupled fluid-struc-
ture system are
r
@uðx; tÞ
@t
þ uðx; tÞ  ruðx; tÞ
 
¼   rpðx; tÞ þ mr2uðx; tÞ þ f eðx; tÞ; ð4Þ
r  uðx; tÞ ¼ 0; ð5Þ
feðx; tÞ ¼
Z
E
FeðX; tÞdðx   χðX; tÞÞdX; ð6Þ
@wðX; tÞ
@t
¼
Z
O
uðx; tÞdðx   χðX; tÞÞdf x; ð7Þ
where OR3 denotes the physical region occupied by the fluid-structure system, and ER3
denotes the region occupied by the immersed solid in the reference configuration. ρ is the
fluid density, p is the pressure, and μ is the viscosity. x = (x1, x2, x3) 2 O denotes the Cartesian
(Eulerian) coordinates, X = (X1, X2, X3) 2 E denotes the material (Lagrangian) coordinates in
the reference configuration. χ(X, t) 2 O gives the physical position of material point X at time
t. Therefore, the physical region occupied by the structure at time t is Oe(t) = χ(E, t), and the
physical domain occupied by the fluid at time t is Of (t) = O − Oe(t). The IB/FE LV model is
shown in Fig 1.
The total Cauchy stress tensor of the coupled fluid-structure system was defined as
σðx; tÞ ¼ σ f þ
σe for x 2 Oe;
0 for x 2 O=Oe;
(
ð8Þ
where σf = −pI + μ[ru +ruT] is the stress tensor of a viscous incompressible fluid, existing in
both the solid and fluid regions. I is the identity matrix, and σe is the elastic stress tensor deter-
mined by the deformation of the immersed structure, defined as
σe ¼
J   1PeFe for x 2 Oe;
0 otherwise;
(
ð9Þ
where F ¼ @χ
@X is the structural deformation gradient and J = det(F), P
e is the first Piola-Kirchoff
stress tensor, consisting of the passive elastic response of the myocardium Pp and the active
stress Pa, that is
Pe ¼ Pp þ Pa: ð10Þ
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Pp was calculated from a strain-invariant based strain-energy function (W) introduced by Hol-
zapfel and Ogden [10],
W ¼
a
2b
exp bðI1   3Þ þ
X
i¼f ;s
ai
2bi
ð exp biðI04i  1Þ
2
  1Þ þ
afs
2bfs
ð exp ðbfsðI8fsÞ
2Þ   1Þ; ð11Þ
and
Pp ¼
@W
@F
  a exp bðI1   3ÞF  T ðx 2 OeÞ; ð12Þ
where a, b, ai and bi (i = f, s, fs) are eight non-negative material parameters. I1 = tr(C), and
C = FT F is the right Cauchy-Green deformation tensor. I 0
4i ¼ max ðI4i; 1Þ (i = f, s),
I4f ¼ f
T
0
Cf0 ¼ f  f , f = Ff0, and I4s ¼ sT0Cs0 ¼ s  s, s = Fs0. f0 and s0 are the fibre and sheet
directions in the reference configuration, as shown in Fig 1. I4f and I4s are the squared stretches
along the fibre and sheet directions, respectively. I 0
4i ensures that the myofibres only exert
stresses when stretched. The coupling effects of the fibre and sheet directions are represented
by I8fs ¼ f
T
0
Cs0. The last term in Eq (12) is to ensure that when F = I, P
p = 0.
The active contraction stress tensor in the current configuration was
σa ¼ Tðx; tÞf 
 f ; ð13Þ
where T(x, t) is the active tension based on the NHS model, triggered by the intracellular CaT
from the modified GPB model, f is the unit vector of the current myofibre direction. The NHS
model parameters were initially obtained from animal experiments. To apply the NHS model
to human heart, we introduced an extra scaling parameter Tscale in Eq (13) as in our previous
study [14],
σa ¼ Tscale Tðx; tÞf 
 f : ð14Þ
LV model construction and implementation. The LV model was constructed from an in
vivo magnetic resonance imaging study of a healthy volunteer [15, 33], and a rule-based
method was used to generate the myocardial fibre and sheet directions [8]. In the simulations,
Fig 1. Schematic illustration of the LV model.Ω is the total computational domain,Ωe is the LV structure, f
denotes the myofibre direction, s denotes the sheet direction, and n denotes the normal orientation of the
plane spanned by the myofibre and sheet directions.
https://doi.org/10.1371/journal.pone.0174834.g001
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the physical domain occupied by the fluid-structure system (O) was taken to be a 15 cm×15
cm×20 cm box that was discretized with 96 × 96 × 128 Cartesian grids. An explicit version of
crank Nicolson-Adams Bashforth scheme was used for time stepping, which required a rela-
tively small time step size (1.22 × 10−4s). The LV model was implemented within the open-
source IBAMR software framework (https://github.com/IBAMR/IBAMR).
The boundary conditions used were such that the longitudinal and circumferential dis-
placements of the basal plane were constrained, whereas the radial displacements of the basal
plane were set free. The no-slip condition was imposed on the left ventricular wall, and a zero
pressure condition was applied on the physical domain of the fluid boundary. A spatially uni-
form pressure was loaded on the endocardial surface. Because it is difficult to measure the LV
pressure in vivo, a population-based ED pressure (8 mmHg) was assumed [15]. In diastolic fill-
ing, the endocardial pressure was linearly increased from 0 to the assumed ED pressure. Then
the myocardium started to contract with increased intracellular CaT and increased systolic
pressure. To simulate the ES state, both the ES pressure (150 mmHg, obtained from the cuff
measurements of the subject) and the peak value of intracellular CaT were maintained until a
steady-state LV dynamics was reached.
The parameters used in the IB/FE LV model were: a = 0.24 kPa, b = 5.08, af = 1.46 kPa, bf =
4.15, as = 0.87 kPa, bs = 1.6, afs = 0.3 kPa, bfs = 1.3 and Tscale = 3.0. These were obtained
inversely by ensuring that the LV volume differences between the clinical measurements and
the simulated values were less than 5% at end-diastole and end-systole [14].
Results
Myocyte contraction
The simulated AP profiles in individual myocytes in one cardiac cycle for the fours cases are
showed in Fig 2(A), in which the spike notch dome morphology can be found. The characteris-
tics of the AP profiles are summarised in Table 2. In Case A, the AP amplitude is 122.33 mV,
which is comparable to published experimental measurements (100 mV [34], 132 mV [35],
and 135 mV [36]). The maximal upstroke velocity in Case A is also within the range of experi-
mental measurements (228 ± 11 V/s [37] to 446 ± 46 V/s [38]). The APD in Case D is much
longer than that in Case A, similarly for the effective refractory period (ERP, measured as the
interval between the AP upstroke and the repolarization level). The resting potential, the
amplitude of the AP, and the maximal upstroke velocity in Cases B, C and D are much lower
than the values in Case A.
Fig 2. Numerical results of myocyte contraction in a single myocyte. Profiles of (A) action potential, (B) Intracellular CaT, and (C) Active tension.
https://doi.org/10.1371/journal.pone.0174834.g002
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The comparison of intracellular CaT in the four cases are shown in Fig 2(B), and their char-
acteristics in Table 2. The intracellular CaT in Case A peaks rapidly with the highest peak value
compared to other cases. In contrast, the CaT in Case D peaks tardily at a much lower value,
almost 63% less than the value in Case A. The intracellular CaT from the two intermediate
cases (Case B and Case C) lie between Case A and Case D. After 0.2s until 0.6s, the CaT in
Case D is slightly higher than others (Fig 2(B)). The maximal upstroke velocity is also highest
in Case A and lowest in Case D.
Fig 2(C) shows the isometric active tension generation for the four cases, and the character-
istics of the generated active tension are also summarized in Table 2. It can be found that the
generated active tension and the maximal upstroke velocity decrease with the decrease of the
intracellular CaT. In Cases C and D, the peak active tension is about one-third of the value in
Case A, with a much lower upstroke velocity. Interestingly, the developed active tension in
Case D after 0.5s is slightly higher than other three cases, which could partially be explained by
the higher CaT in Case D after 0.2s as shown in Fig 2(B), however, the difference in active ten-
sion is not much.
LV contraction
The deformed end-diastolic LV geometries are same in Cases A and D because of the same
passive material properties and boundary conditions used, shown in Fig 3(A). The deformed
end-systolic geometry in Case A is shown in Fig 3(B). In Case A, the LV cavity volume is 145
mL at end-diastole and 61 mL at end-systole, with an ejection fraction (EF) of 57.55%, which
are in agreement with the measured end-diastolic and end-systolic volumes (ED: 143 mL, ES:
64 mL). The deformed end-systolic geometry in Case D is showed in Fig 3(C), the correspond-
ing LV cavity volume is 189 mL, and the mean myofibre strain is 0.07 ± 0.06. The larger end-
systolic LV cavity volume and the positive systolic myofibre strain in Case D suggest that the
LV model does not contract. This is largely because of the much lower level of intracellular
CaT in Case D, which results in a much lower systolic active tension. The average systolic
active tension in Case D is 50.2 ± 4.3 kPa, a 38% less than that of Case A (81.53 ± 21.0 kPa).
Table 2. Characteristics of the active potential profiles, the intracellular CaT, and the active tension generation in a single myocyte.
Case A Case B Case C Case D
Action Potential
APD90 (ms) 270.19 301.91 341.77 399.89
Resting potential (mV) -80.55 -80.00 -79.17 -77.86
amplitude (mV) 123.36 123.87 123.86 122.42
maximal upstroke velocity (V/s) 370.70 354.71 330.71 291.18
ERP (ms) 261.06 291.23 330.00 385.89
Intracellular CaT
Peak (μM) 0.9752 0.6712 0.4714 0.3690
Time to peak of CaT (s) 0.039 0.054 0.076 0.106
Maximal upstroke velocity (μM/s) 139.54 45.97 14.19 5.10
CaT amplitude (μM) 0.87 0.56 0.36 0.25
Active Tension
Peak (kPa) 9.87 5.72 3.85 3.31
Rate of tension development (kPa/s) 211.96 99.20 43.62 22.98
Time from peak tension to 50% relaxation (RT50) (s) 0.182 0.294 0.412 0.497
https://doi.org/10.1371/journal.pone.0174834.t002
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The lower myocardial active tension in Case D agrees with the cellular level results: the isomet-
ric tension in Case D is 66% less compared to the peak value in Case A.
Remodelling in myocytes, such as increasing myocardial contractility (i.e Tscale), decreasing
the afterload (i.e. the end-systolic pressure), or increasing diastolic filling pressure (i.e. the ED
pressure), is needed to maintain the minimum required pump function in a failing heart [2,
39]. We further investigated the effects of decreasing the end-systolic pressure and increasing
Tscale on LV pump function in Case D, and the results are shown in Fig 4(A). As expected, the
LV end-systolic volume decreases with the decrease of the end-systolic pressure or the increase
of Tscale. Fig 4(B) shows the corresponding changes of LV stroke volume, defined as ED vol-
ume—ES volume. When the end-systolic pressure is 100 mmHg and Tscale is 6.0, the end-sys-
tolic volume is 116 mL and an EF of 19% is achieved in Case D, which still indicates a severe
heart failure. The LV stroke volume in case A is 83.60 mL, almost four times greater. Fig 4(C)
is the average systolic active tension in Case D. For a given end-systolic pressure, a higher Tscale
is associated with a higher active tension and a stronger contraction. On the other hand, for a
given Tscale, although a lower end-systolic pressure reduces the active tension generation, the
LV stroke volume actually increases. This is because the active tension is length and strain-rate
dependent, therefore a lower end-systolic pressure means that the myocardium is able to con-
tract early and quickly, leading to a larger LV stroke volume. Fig 4 shows that only when the
end-systolic pressure is below 120 mmHg, the LV can pump the blood into the systemic circu-
lation. These results may suggest that it is insufficient to improve the pump performance by
simply increasing the myocardial contraction, or reducing the end-systolic pressure.
Fig 5(A) shows the end-diastolic and end-systolic volumes under different end-diastolic
pressures in case D for a given end-systolic pressure (= 100 mmHg) and Tscale(= 6.0). The end-
diastolic volume increases with the increase of the end-diastolic pressure, which is consistent
Fig 3. Deformed LV structures. A: Deformed LV structures at end-diastole; B: the end-systolic state for
Case A; C: the end-systolic state for Case D.
https://doi.org/10.1371/journal.pone.0174834.g003
Fig 4. LV pump function in case D under different end-systolic pressures and Tscale. A: The end-systolic volume; B: LV stroke volume; C:
Average systolic active tension.
https://doi.org/10.1371/journal.pone.0174834.g004
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with the Frank-Starling law of the heart. On the other hand, the end-systolic volume does not
change much. The LV stroke volume versus end-diastolic pressure is shown in Fig 5(B). The
LV stroke volume and EF reach their maximum values (47mL, 29.19%) at end-diastolic pres-
sure = 16 mmHg, but still less than the value in Case A. The results suggest that with increased
end-diastolic pressure, the left ventricle can pump more blood, which is beneficial in terms of
meeting body’s blood demand. However, studies have found that elevated diastolic filling pres-
sure may associate with terminal heart failure in the longer run [40, 41].
Discussion
From biomechanical perspective, myocaridal dysfunction could be considered as biomechanical
model with interrelated and intricate changes and remodelling in cardiac structure and function
as the result of downstream biological abnormalities [2]. Advanced biomechanical modelling of
heart mechanics with multi-scale and multi-physics may hold the potential to improve our
understanding of failing hearts and shed lights on effective treatments [3]. This computational
work, based on an advance human myocyte electrophysiological model, a myofilament model
for excitation-contraction coupling, and a multi-physics organ-level LV mechanics model, dem-
onstrates that a multi-scale biomechanical model can be used to investigate the effects of down-
stream biological abnormalities on ventricular pump function. Once validated, it will provide a
platform to understand the functional and structural remodelling in failing hearts.
Using this multi-scale LV model, we found that (1) profiles of AP, intracellular CaT and
active tension are very different at cellular level from healthy to failing states; (2) a lower CaT
can lead to a much less active tension generation; and (3) a lower intracellular CaT in individ-
ual myocytes can result in LV pump function failure even with increased myocardial contrac-
tility, decreased afterload, and increased diastolic filling pressure. Our modelling results at
both the cellular and tissue levels for one healthy and diseased LV cases showed good agree-
ment with experimental measurements and earlier studies, additional comparison is provided
in S1 Table.
Specifically, the APD in the failing case (D) is prolonged compared to the value in the
healthy case (A) because of the much slower rate of repolarization in Case D, this is consistent
with experimental findings [42, 43]. As the myocardial dysfunction worsens (from Case A to
Case D), the peak and the maximal upstroke velocity of intracellular CaT decreases, and the
curve gradually flattens. With decreased intracellular CaT and its upstroke velocity, the gener-
ated active tension also decreases, to almost 66% in Case D. Although the CaT in Case D is
Fig 5. LV pump function under different end-diastolic pressures in case D. A: The end-diastolic and
end-systolic volumes; B: LV stroke volume.
https://doi.org/10.1371/journal.pone.0174834.g005
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higher than other cases after 0.2s, the active tension in Case D is generally lower than in Case
A. This suggests that in a failing state, the remodelling in ion dynamics (by prolonging APD
and increasing CaT in the later contraction phase) has limited effect on active tension genera-
tion. Therefore, our study suggests that a well-balanced physiological Ca2+ handling mecha-
nism is an essential component in maintaining normal myocyte contractile function, which
agrees with [44].
By simulating a pseudo-isometric experiment in a myocyte, we found that the active tension
from Case D is much lower compared to Case A. To see how this affects the LV performance,
we embedded the modified GPB model into a dynamic LV model [14]. Our results show that
the reduction in average systolic active tension across the whole LV in Case D is 39% com-
pared to the Case A, and no blood can be pumped out (the LV cavity volume at end-systole is
greater than its end-diastolic volume). This is when sudden death occurs.
A decline in LV pump function will activate various compensatory mechanisms to restore a
normal homeostatic cardiovascular function [2, 39]. These include a higher heart rate, myocyte
hypertrophy, and increased LV end-diastolic volume (i.e. through elevated diastolic filling
pressure). Treatments of heart failure typically aims to preserve the cardiac output by reducing
the blood pressure (the afterload) using intravenous vasodilators, or increasing the myocardial
contractility using positive iontropes [45, 46]. Indeed, our results show that decreased end-sys-
tolic pressure and increased myocardial contractility are not enough to maintain normal LV
pump function. For instance, with the end-systolic pressure of 100 mmHg, the LV model can
pump the blood out only when Tscale is above 4. However, the pump function is compromised
even when Tscale is increased to 6, the LV stroke volume is only 29 mL, which is far less com-
pared to the healthy Case A (83 mL). Moreover, continuous increase of the myocardial con-
tractility can deteriorate the LV function in the longer term leading to cardiac de-
compensation. It is perhaps for this reason that some inotropic therapies increased, rather
than decreased, mortality [47].
In addition, the capacity of decreasing afterload or increasing myocardial contractility is
not without limitation, therefore, other compensation mechanisms will be activated, such as
elevated diastolic filling pressure through the Frank-Starling law of the heart [39, 40]. In case
D, when the end-systolic pressure is 100 mmHg and Tscale is 6, the LV stroke volume increases
with the increase of end-diastolic pressure. The LV stroke volume reaches 48 mL when the
end-diastolic pressure is 16 mmHg. It is expected that with further increased end-diastolic
pressure, LV stroke volume will increase further. However, clinical observations suggest that
the elevated diastolic filling pressure would reflect patients at increased risk of developing late
clinical symptoms of heart failure in the long term [41], even though it can increase the LV
stroke volume in the short term as suggested by our models.
There are two recent mathematical descriptions of human ventricle myocytes, the GPB
model [22] and the OVVR model [21]. Both models can match experimental data well though
discrepancies exist in cellular and tissue levels [27, 48]. In this study the GPB model was cho-
sen because it is adequate to analyse action potential, Ca2+ dynamics. Furthermore, the GPB
model has been demonstrated to reproduce the electrical changes of failing myocytes due to
ion channel and transporter remodelling [28, 48]. However, the issue with linking the GPB
model to the NHS model is that the peak CaT in the GPB model is less than 1μM, which is not
compatible with the active tension generation model in the multi-scale LV model. Thus, we
had to increase two diffusion constants so that the peak CaT is around 1μM. OVVR model, on
the other hand, has a CaT amplitude of about 1μM. The adjustments of JCajuncsl and JCaslmyo
may not be the ideal way to tune the GPB model to obtain the required CaT profile, a carefully
designed calibration procedure is required. Alternatively, one can use a different myofilament
model to make the two models compatible since the NHS model was developed based on
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animal experiments. Despite of this, our modelling results from the adopted GPB model agree
well with prior studies and experiments, for example, in the failing state, the CaT amplitude
decreases, its rise and decay rates are slowed down [49], additional comparisons with other
studies are provided in a supplementary table. We expect it will work equally well by replacing
the GPB model with the OVVR model in our model, and it will be interesting to compare the
behaviour of both models in a multi-scale biomechanical myocardial model, and explore other
myofilament models developed for human.
The remodelling of the failing heart occurs in many aspects at both cellular and organ levels,
in terms of structure [50], electrophysiology [51], metabolism [52], and couplings among
them [16]. Cardiomyocytes in healthy and failing hearts differ in numerous ways, such as pro-
longation of AP, altered Ca2+ handing, intracellular Na+ accumulation, and impaired electro-
mechanical coupling [16, 44, 51]. It is well known that failing myocytes have abnormal CaT,
with decreased amplitude and slowed kinetics [49]. Except for the functional remodelling of
ion channels and pumps as described in the adopted GPB model, cellular structural remodel-
ling is also recognized as one of the underlying causes for altered intracellular Ca2+ homeosta-
sis. These include alternations in the T-tubule structure [53], micro-architecture changes in
sarcoplasmic reticulum [54], and alterations in molecular and biochemical structure of myofi-
brils [55]. Furthermore, metabolic remodelling also contributes to the impaired excitation-
contraction coupling due to ATP deficiency [52]. In this study, we only studied the effects of
CaT from different failing stages on myocardial active contraction that is caused by ion chan-
nel and transporter remodelling [28, 48]. However, we expect that other types of remodelling
mechanism can be ready implemented in our model by including more detailed descriptions
of related remodelling process.
Similar as the GPB model used here, the structural remodelling of the myocyte is not mod-
elled in the NHS model [31]. An anatomical multi-scale myocardial description from sub-cel-
lular to organ levels is needed in order to capture the spatially varied structural remodelling.
However, there are many challenges in following this approach [56]. Even if one can develop
detailed mathematical description based on proper upscaling, to solve this a model also
requires efficient numerical methods and high-performance computers.
Other limitations of the work include: (1) we have not thoroughly analysed the effects of
individual ion channel remodelling on myocardial active contraction, but focused on how
CaT profiles from different failing stages affect LV pump function; (2) we assumed that the LV
contraction was spatially homogeneous and temporally simultaneous, which has been widely
adopted in heart simulations [6]. This treatment has limitations that the LV model will not be
applicable to ischemic myocardial dysfunction, i.e. myocardial infarction, but more relevant to
nonischemics myocardial dysfunction, such as ventricular fibrosis; (3) we also only simulated
the end-diastolic and end-systolic phases of LV dynamics, not the whole cardiac cycle which
involves interactions of the heart valves. Therefore, the developed multi-scale myocardial con-
traction model should be considered as a phenotype representation of failing hearts, rather
than a personalized model. Nevertheless, this computational work provides a multi-scale plat-
form for studying the effects of myocardial remodelling on LV pump function in a biomechan-
ical perspective.
Conclusion
In this study, we have modelled myocardial excitation-contraction coupling both at cellular
and organ levels by incorporating a modified GPB model and the NHS model at healthy and
failing states. The LV model was implemented in an in-house developed IB/FE framework.
Results show that the active tension decreases with the decrease of intracellular CaT both at
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cellular and organ levels. In a failing heart, decreased systolic blood pressure, enhanced con-
tractility and elevated diastolic filling pressure can improve heart pump function in the short
term (i.e. increased stroke volume), however, they may lead to terminal heart failure in a lon-
ger term if a balanced physiological calcium ion handling mechanism is not restored. This
study forms part of the continuous effort in multi-scale electro-mechanics modelling for clini-
cal problems, and provides a platform to study remodelling in a failing heart from a bio-
mechanical perspective.
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